WILMINGTON, Del., Aug. 2, 2016 /PRNewswire/ — Today, Chemours is announcing that it will locate its global headquarters in Wilmington, Delaware.
“While we like to think of ourselves as a 200-year-old start-up, we’ve been an independent, publicly traded company for only just over a year now,” said President and CEO Mark Vergnano. “We’ve accomplished a good deal in a short time, standing up Chemours and making a host of decisions that ensure a sound and prosperous future. We have considered a number of locations for our world headquarters, but in the end it came down to what locale makes the most financial sense, offers our current workforce the right combination of amenities and conveniences, and allows us to attract great talent. Wilmington is that place, and we look forward to being part of its future growth.”
Chemours began evaluating headquarters location options more than 6 months ago with Delaware, New Jersey, and Pennsylvania all under active consideration. The company followed a disciplined evaluation process against a range of criteria, including quality of life for employees, access to a strong talent pool, and a positive, long-term financial case for the company.
“Chemours has a first-rate workforce, and the state of Delaware has a rich talent pool, so we believe Delaware’s a great place for maintaining our superb employee base. That’s a competitive advantage for us,” Vergnano added.
Recent changes to the state’s corporate tax structure brought about by the Delaware Competes Act, which was approved earlier this year with overwhelming, bi-partisan support of the Delaware legislature, were key components in Chemours’ decision.
“Today’s announcement is the result of strong support from Delaware’s elected officials at the federal, state and local levels, notably Governor Jack Markell, who spearheaded passage of the Delaware Competes Act along with Senate President Pro-Tem Patricia Blevins and House Majority Leader Valerie Longhurst. Solid relationships with Wilmington Mayor Dennis Williams, United States Senators Tom Carper, and Chris Coons, as well as Congressman John Carney also helped drive our decision. Chemours has enjoyed substantive dialogue with these leaders about issues of importance to our company, employees and future,” said Vergnano.
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. Our flagship products include prominent brands such as Teflon, Ti-Pure™, Krytox, Viton™, Opteon™ and Nafion™. Chemours has approximately 8,000 employees across 35 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information please visit chemours.com.
This press release contains forward-looking statements, which often may be identified by their use of words like “plans,” “expects,” “will,” “believes,” “intends,” “estimates,” “anticipates” or other words of similar meaning. These forward-looking statements address, among other things, our anticipated future operating and financial performance, business plans and prospects, transformation plans, resolution of environmental liabilities, litigation and other contingencies, plans to increase profitability, our ability to pay or the amount of any dividend, and target leverage that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. The matters discussed in these forward-looking statements also are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements, as further described in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the fiscal year ended December 31, 2015. Chemours undertakes no duty to update any forward-looking statements.